Literature DB >> 21348496

Specific hydroxy fatty acids in royal jelly activate TRPA1.

Yuko Terada1, Masataka Narukawa, Tatsuo Watanabe.   

Abstract

This is the first report of TRPA1 activation by fatty acids. Activation of TRPA1 and TRPV1 induces thermogenesis and energy expenditure enhancement. In this study, we searched for novel agonists of TRPA1 and TRPV1 from a nonpungent food, royal jelly (RJ). We measured the activation of human TRPA1 and TRPV1 by RJ extracts and found that the hexane extract contains TRPA1 agonists. The main functional compounds in the hexane extract were trans-10-hydroxy-2-decenoic acid (HDEA) and 10-hydroxydecanoic acid (HDAA). These are characteristic fatty acids of RJ. Their EC50 values were about 1,000 times larger than that of AITC, and their maximal responses were equal. They activated TRPA1 more strongly than TRPV1. Their EC50 values for TRPV1 were 2 times larger, and the maximal response was less than half of that for TRPA1. Next, we studied the potencies of other lipid components for both receptors. Most of them have higher affinity to TRPA1 than TRPV1. Among them, dicarboxylic acids showed equal efficacy for both receptors, but those are present in only small amounts in RJ. We concluded that the main function of RJ is TRPA1 activation by HDEA and HDAA, the major components of the RJ lipid fraction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21348496     DOI: 10.1021/jf1041646

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  23 in total

1.  Effects of royal jelly supplementation on body weight and dietary intake in type 2 diabetic females.

Authors:  Samira Pourmoradian; Reza Mahdavi; Majid Mobasseri; Elnaz Faramarzi; Mehrnoosh Mobasseri
Journal:  Health Promot Perspect       Date:  2012-12-28

Review 2.  Therapeutic Properties of Bioactive Compounds from Different Honeybee Products.

Authors:  Laura Cornara; Marco Biagi; Jianbo Xiao; Bruno Burlando
Journal:  Front Pharmacol       Date:  2017-06-28       Impact factor: 5.810

Review 3.  Review of the anticancer activities of bee products.

Authors:  Pongsathon Premratanachai; Chanpen Chanchao
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

4.  Eusociality is linked to caste-specific differences in metabolism, immune system, and somatic maintenance-related processes in an ant species.

Authors:  Fabrice Bertile; Dimitri Heintz; Martin Quque; Claire Villette; François Criscuolo; Cédric Sueur
Journal:  Cell Mol Life Sci       Date:  2021-12-31       Impact factor: 9.261

Review 5.  Health Promoting Properties of Bee Royal Jelly: Food of the Queens.

Authors:  Nicolas Collazo; Maria Carpena; Bernabe Nuñez-Estevez; Paz Otero; Jesus Simal-Gandara; Miguel A Prieto
Journal:  Nutrients       Date:  2021-02-07       Impact factor: 5.717

6.  Five hTRPA1 Agonists Found in Indigenous Korean Mint, Agastache rugosa.

Authors:  Hana Moon; Min Jung Kim; Hee Jin Son; Hae-Jin Kweon; Jung Tae Kim; Yiseul Kim; Jaewon Shim; Byung-Chang Suh; Mee-Ra Rhyu
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

7.  The TRPA1 agonist, methyl syringate suppresses food intake and gastric emptying.

Authors:  Min Jung Kim; Hee Jin Son; Seo Hyeon Song; Myungji Jung; Yiseul Kim; Mee-Ra Rhyu
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

8.  In Vitro Anti-Inflammatory Effects of Three Fatty Acids from Royal Jelly.

Authors:  Yi-Fan Chen; Kai Wang; Yan-Zheng Zhang; Yu-Fei Zheng; Fu-Liang Hu
Journal:  Mediators Inflamm       Date:  2016-10-25       Impact factor: 4.711

9.  Formulation of Ocular In Situ Gels with Lithuanian Royal Jelly and Their Biopharmaceutical Evaluation In Vitro.

Authors:  Kristina Perminaite; Mindaugas Marksa; Monika Stančiauskaitė; Tadas Juknius; Aidas Grigonis; Kristina Ramanauskiene
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411

10.  Oral administration of royal jelly restores tear secretion capacity in rat blink-suppressed dry eye model by modulating lacrimal gland function.

Authors:  Toshihiro Imada; Shigeru Nakamura; Naoki Kitamura; Izumi Shibuya; Kazuo Tsubota
Journal:  PLoS One       Date:  2014-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.